Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Blood doping and its detection.
Jelkmann W, Lundby C. Jelkmann W, et al. Blood. 2011 Sep 1;118(9):2395-404. doi: 10.1182/blood-2011-02-303271. Epub 2011 Jun 7. Blood. 2011. PMID: 21652677 Review.
Erythropoietin.
Jelkmann W. Jelkmann W. J Endocrinol Invest. 2003 Sep;26(9):832-7. doi: 10.1007/BF03345232. J Endocrinol Invest. 2003. PMID: 14964434 Review.
The role of the liver in the production of thrombopoietin compared with erythropoietin.
Jelkmann W. Jelkmann W. Eur J Gastroenterol Hepatol. 2001 Jul;13(7):791-801. doi: 10.1097/00042737-200107000-00006. Eur J Gastroenterol Hepatol. 2001. PMID: 11474308 Review.
Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin.
Wagner KF, Katschinski DM, Hasegawa J, Schumacher D, Meller B, Gembruch U, Schramm U, Jelkmann W, Gassmann M, Fandrey J. Wagner KF, et al. Among authors: jelkmann w. Blood. 2001 Jan 15;97(2):536-42. doi: 10.1182/blood.v97.2.536. Blood. 2001. PMID: 11154234
Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1.
Hellwig-Bürgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Hellwig-Bürgel T, et al. Among authors: jelkmann w. Blood. 1999 Sep 1;94(5):1561-7. Blood. 1999. PMID: 10477681
Expression of the thrombopoietin gene in human fetal and neonatal tissues.
Wolber EM, Dame C, Fahnenstich H, Hofmann D, Bartmann P, Jelkmann W, Fandrey J. Wolber EM, et al. Among authors: jelkmann w. Blood. 1999 Jul 1;94(1):97-105. Blood. 1999. PMID: 10381502
Evidence against a major role for Ca2+ in hypoxia-induced gene expression in human hepatoma cells (Hep3B).
Metzen E, Fandrey J, Jelkmann W. Metzen E, et al. Among authors: jelkmann w. J Physiol. 1999 Jun 15;517 ( Pt 3)(Pt 3):651-7. doi: 10.1111/j.1469-7793.1999.0651s.x. J Physiol. 1999. PMID: 10358107 Free PMC article.
Erythropoiesis stimulating agents and techniques: a challenge for doping analysts.
Jelkmann W. Jelkmann W. Curr Med Chem. 2009;16(10):1236-47. doi: 10.2174/092986709787846668. Curr Med Chem. 2009. PMID: 19355882 Review.
Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
Fjornes T, Wiedemann GJ, Sack K, Jelkmann W. Fjornes T, et al. Among authors: jelkmann w. Oncol Rep. 1998 Jan-Feb;5(1):81-6. Oncol Rep. 1998. PMID: 9458299 Clinical Trial.
Erythropoietin and the vascular wall: the controversy continues.
Jelkmann W, Elliott S. Jelkmann W, et al. Nutr Metab Cardiovasc Dis. 2013 Dec;23 Suppl 1:S37-43. doi: 10.1016/j.numecd.2012.04.002. Epub 2012 Jun 7. Nutr Metab Cardiovasc Dis. 2013. PMID: 22682530 Review.
250 results
Jump to page
Feedback